Literature DB >> 15118430

Imipramine for therapy resistant enuresis: a retrospective evaluation.

Simon Gepertz1, Tryggve Nevéus.   

Abstract

PURPOSE: Imipramine has a proven effect in enuresis but is now seldom used. We reviewed the records of children who had been treated with imipramine to determine prognostic indicators.
MATERIALS AND METHODS: The records of all enuretic children treated with imipramine at our clinic were retrospectively evaluated, with special emphasis on history, and for most children bladder volume, renal concentrating capacity and urine production.
RESULTS: All 49 children included in the study had previously received desmopressin, alarm and anticholinergic treatment without success. Of the children 31 (64.6%) were responders (R), with at least 50% reduction in enuresis frequency (22 became completely dry) and 17 (35.4%) were nonresponders (NR). Older age (R 11.4 +/- 3.4, NR 8.7 +/-1.8 years, p = 0.004) and low spontaneous bladder capacity (R 2.6 +/- 0.9, NR 3.4 +/- 0.9 ml/kg body weight, p = 0.03) were prognostically favorable, whereas constipation (p = 0.02) and a history of daytime incontinence (p = 0.04) indicated poor prognosis. Ten children experienced nausea or other minor problems. Seven children with attention deficit and hyperactivity became more focused during treatment.
CONCLUSIONS: Imipramine is a useful treatment for enuresis when everything else has failed, especially among older children. Factors related to detrusor function provide prognostic information.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15118430     DOI: 10.1097/01.ju.0000110613.51078.93

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  13 in total

Review 1.  Medical management of nocturnal enuresis.

Authors:  Aniruddh V Deshpande; Patrina H Y Caldwell
Journal:  Paediatr Drugs       Date:  2012-04-01       Impact factor: 3.022

2.  Commentary: enuresis and ADHD in older children and an adolescent treated with stimulant medication: a case series.

Authors:  Philippe Robaey
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2011-02

3.  [Evaluation and management of enuresis. An update].

Authors:  M Riccabona
Journal:  Urologe A       Date:  2010-07       Impact factor: 0.639

4.  Rs 6313 polymorphism in 5-hydroxytryptamine receptor 2A gene association with polysymptomatic primary nocturnal enuresis.

Authors:  Chang-Ching Wei; Lei Wan; Wen-Yuan Lin; Fuu-Jen Tsai
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

Review 5.  An interprofessional approach to managing children with treatment-resistant enuresis: an educational review.

Authors:  Patrina H Y Caldwell; Melissa Lim; Gail Nankivell
Journal:  Pediatr Nephrol       Date:  2017-11-06       Impact factor: 3.714

6.  Tolterodine and imipramine in refractory enuresis; a placebo-controlled crossover study.

Authors:  Tryggve Nevéus; Kjell Tullus
Journal:  Pediatr Nephrol       Date:  2007-11-15       Impact factor: 3.714

Review 7.  Tricyclic and related drugs for nocturnal enuresis in children.

Authors:  Patrina H Y Caldwell; Premala Sureshkumar; Wicky C F Wong
Journal:  Cochrane Database Syst Rev       Date:  2016-01-20

Review 8.  Nocturnal enuresis-theoretic background and practical guidelines.

Authors:  Tryggve Nevéus
Journal:  Pediatr Nephrol       Date:  2011-01-26       Impact factor: 3.714

Review 9.  Nocturnal enuresis: A topic review and institution experience.

Authors:  John Michael DiBianco; Chad Morley; Osama Al-Omar
Journal:  Avicenna J Med       Date:  2014-10

Review 10.  Comorbidity of ADHD and incontinence in children.

Authors:  Alexander von Gontard; Monika Equit
Journal:  Eur Child Adolesc Psychiatry       Date:  2014-07-01       Impact factor: 4.785

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.